Ambev S.A. (NYSE:ABEV – Get Free Report) insider Paulo Andre Zagman sold 136,250 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The shares were sold at an average price of $3.41, for a total value of $464,612.50. Following the completion of the transaction, the insider directly owned 230,535 shares in the company, valued at approximately $786,124.35. The trade was a 37.15% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Ambev Stock Performance
Shares of ABEV opened at $3.23 on Friday. The business’s 50 day moving average is $3.12 and its two-hundred day moving average is $2.88. Ambev S.A. has a 52-week low of $2.10 and a 52-week high of $3.45. The firm has a market cap of $50.83 billion, a price-to-earnings ratio of 16.97, a PEG ratio of 1.79 and a beta of 0.64. The company has a quick ratio of 0.78, a current ratio of 1.03 and a debt-to-equity ratio of 0.02.
Ambev (NYSE:ABEV – Get Free Report) last announced its earnings results on Wednesday, May 6th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.05. Ambev had a return on equity of 16.63% and a net margin of 17.69%.The company had revenue of $4.32 billion for the quarter, compared to analyst estimates of $4.38 billion. Analysts forecast that Ambev S.A. will post 0.21 EPS for the current fiscal year.
Ambev Announces Dividend
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on the company. Weiss Ratings lowered Ambev from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, May 6th. Wall Street Zen raised Ambev from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. UBS Group upped their price target on Ambev from $2.65 to $2.90 and gave the company a “sell” rating in a research report on Thursday, May 14th. Finally, Barclays upped their price target on Ambev from $3.00 to $3.50 and gave the company an “equal weight” rating in a research report on Wednesday, May 6th. Five equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Ambev has a consensus rating of “Reduce” and a consensus price target of $3.09.
View Our Latest Report on ABEV
Institutional Investors Weigh In On Ambev
Several institutional investors and hedge funds have recently made changes to their positions in the company. Integrated Wealth Concepts LLC bought a new position in Ambev during the 1st quarter worth $26,000. Millennium Management LLC grew its stake in Ambev by 62.5% during the 1st quarter. Millennium Management LLC now owns 2,399,472 shares of the company’s stock worth $5,591,000 after buying an additional 922,566 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in Ambev by 13.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 5,000,107 shares of the company’s stock worth $11,650,000 after buying an additional 582,153 shares during the last quarter. Focus Partners Wealth bought a new position in Ambev during the 1st quarter worth $33,000. Finally, Acadian Asset Management LLC bought a new position in Ambev during the 1st quarter worth $264,000. 8.13% of the stock is owned by institutional investors and hedge funds.
Ambev Company Profile
Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.
The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.
See Also
- Five stocks we like better than Ambev
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for Ambev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev and related companies with MarketBeat.com's FREE daily email newsletter.
